 Co-Diagnostics NASDAQ:CODX Inc posted second-quarter results that saw pre-tax income of 11.9 million and year-over-year revenue gains driven by sales of the companys Logix Smart COVID-19 Test. For the period ended June 30, 2021, the Salt Lake City, Utah-based molecular diagnostics company reported revenue of 27.4 million, up 13.8 from the second quarter in 2020. 